Moderna commits funding to increase global supply of its COVID-19 vaccine

Moderna, manufacturer of one of the three main COVID-19 vaccines being circulated in the U.S., said Thursday it's making new funding commitments to increase supply, which the company said will increase global supply of the vaccine to 3 billion doses by 2022.

Read the full post at News Feed
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive